Publication | Closed Access
Advances In Research On Genome Editing Crispr-Cas9 Technology.
18
Citations
0
References
2019
Year
CRISPR/Cas9 systems will undoubtedly revolutionize the study and treatment of both immunologic and allergic diseases. Concerned authorities should formulate and authorize such laws and regulations that permit the safe and ethical use of this emerging technology for basic research and clinical purposes.